Stockreport

Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]

Lexaria Bioscience Corp.  (LEXX) 
PDF Lexaria Bioscience is advancing a patented oral delivery platform that improved tolerability in a clinical study by reducing adverse events by up to 50%, targeting a la [Read more]